Veterinary practices (NAICS 541940 — Veterinary Services) access SBA 7(a) for practice acquisition and equipment packages, equipment financing for diagnostic imaging and surgical systems, working capital lines for pharmaceutical inventory and payroll, and veterinary-practice-specific term loans — shaped by the industry's cash-pay revenue model, high diagnostic equipment costs, and the strong DSCR profiles that make veterinary medicine one of the most SBA-financed professional practices.
Veterinary practices (NAICS 541940 — Veterinary Services) differ from human healthcare primarily in their revenue model: approximately 80–85% of companion animal veterinary revenue is paid at point of service by pet owners, with the remaining 15–20% reimbursed through pet insurance carriers. This cash-pay-dominant model means veterinary practices have deposit patterns closer to retail businesses than to insurance-dependent healthcare — high daily transaction volume, rapid cash collection, and minimal AR compared to medical or dental practices. The sector is also experiencing structural growth: AVMA (American Veterinary Medical Association) data shows companion animal households in the U.S. have grown consistently, with pet ownership and veterinary spending per pet both increasing post-2020. Equipment intensity is high: a fully equipped small animal practice requires radiography ($25,000–$60,000), anesthesia machines ($5,000–$20,000 each), surgical tables, centrifuges, hematology analyzers, and ultrasound units — with larger practices adding digital DR X-ray ($40,000–$80,000) and CT scanners ($200,000+). The Federal Reserve Small Business Credit Survey 2024 documents professional services businesses including veterinary practices as having consistently strong SBA loan approval rates.
Veterinary practice lenders evaluate bank statement deposit patterns as the primary revenue signal — unlike human healthcare, there is minimal insurance AR lag in small animal companion practices. Daily deposit patterns reflect transaction volume and average transaction value; a companion animal practice with 30 appointments/day at $175 average generates $5,250/day in gross collections, with same-day cash settlement. This clean cash flow pattern produces bank statement DSCR calculations that are straightforward compared to insurance-heavy healthcare. DEA Schedule II controlled substance registration is a material underwriting pre-flight check: veterinary practices dispensing controlled substances (opioid analgesics, barbiturates for euthanasia) must hold current DEA registration under DEA Practitioner's Manual for Veterinarians — a lapsed or revoked DEA registration is an SBA eligibility disqualifier. State veterinary licensing board requirements vary by state but include annual license renewal and continuing education compliance — SBA lenders verify currency. Pharmaceutical and supply inventory — vaccines, medications, surgical supplies — represents 15–25% of revenue in a typical companion animal practice, and lenders evaluate inventory management practices as an operational quality signal.
Underwriters evaluating veterinary practices focus on: DEA Schedule II registration currency — dispensing controlled substances without current DEA registration is a federal violation and SBA eligibility disqualifier; state veterinary license renewals and board complaint history — any disciplinary action is a material underwriting concern; practice type and specialty mix — emergency/specialist veterinary practices generate higher revenue per visit but face greater staffing cost and revenue variability than general companion animal practices; single-veterinarian concentration — solo-DVM practices have key-man risk; multi-veterinarian practices with documented associate income coverage are more resilient; pet insurance penetration — practices with high pet insurance client share face growing insurance AR cycles as pet insurance adoption increases; equipment age and maintenance status — diagnostic equipment that is out of warranty or behind on calibration service affects both practice revenue capacity and collateral value; and competition from corporate veterinary consolidators (VCA, Banfield, BluePearl) — proximity to a corporately-owned practice affects patient volume and revenue trajectory.